As peptide-based blockbusters such as semaglutide enter the Indian market, regulators are examining gaps in drug laws governing biological products.
Hot this week
Free News - Where voices unite, stories flourish, and community thrives through open dialogue and meaningful connections.
Get important news delivered directly to your inbox and stay connected!
